Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.
暂无分享,去创建一个
U. Gullberg | S. Obad | K. Drott | T. Olofsson | N. Mechti
[1] R. Andreesen,et al. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. , 2006, Virology.
[2] S. Nisole,et al. TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.
[3] T. Olofsson,et al. Clonogenicity, gene expression and phenotype during neutrophil versus erythroid differentiation of cytokine‐stimulated CD34+ human marrow cells in vitro , 2004, British journal of haematology.
[4] Å. Borg,et al. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells , 2004, Oncogene.
[5] Pier Paolo Pandolfi,et al. The Role of PML in Tumor Suppression , 2002, Cell.
[6] C. Gongora,et al. The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[7] J. Downing,et al. HERF1, a Novel Hematopoiesis-Specific RING Finger Protein, Is Required for Terminal Differentiation of Erythroid Cells , 1999, Molecular and Cellular Biology.
[8] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[9] N. Mechti,et al. Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*) , 1995, The Journal of Biological Chemistry.